Citadel Advisors
ASTH icon

Citadel Advisors’s Astrana Health ASTH Stock Holding History

Citadel Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.04M Buy
+83,000
New +$1.97M ﹤0.01% 6031
2025
Q4 		– Sell
-391,000
Closed -$11.1M – 14323
2025
Q3 		$11.1M Buy
391,000
+379,500
+3,300% +$10.3M ﹤0.01% 3127
2025
Q2 		$286K Buy
11,500
+2,600
+29% +$73.2K ﹤0.01% 9917
2025
Q1 		$276K Sell
8,900
-500
-5% -$16.7K ﹤0.01% 9779
2024
Q4 		$296K Sell
9,400
-576,900
-98% -$27.4M ﹤0.01% 9677
2024
Q3 		$34M Buy
586,300
+567,000
+2,938% +$27.9M 0.01% 1554
2024
Q2 		$783K Sell
19,300
-340,400
-95% -$13.5M ﹤0.01% 7093
2024
Q1 		$15.1M Buy
359,700
+336,300
+1,437% +$13.1M ﹤0.01% 2392
2023
Q4 		$896K Sell
23,400
-8,800
-27% -$293K ﹤0.01% 6890
2023
Q3 		$993K Sell
32,200
-40,000
-55% -$1.38M ﹤0.01% 6563
2023
Q2 		$2.28M Buy
72,200
+64,400
+826% +$2.21M ﹤0.01% 4933
2023
Q1 		$284K Sell
7,800
-2,000
-20% -$70K ﹤0.01% 9481
2022
Q4 		$290K Sell
9,800
-79,800
-89% -$2.57M ﹤0.01% 9385
2022
Q3 		$3.49M Buy
89,600
+75,400
+531% +$3.45M ﹤0.01% 4503
2022
Q2 		$548K Sell
14,200
-47,000
-77% -$1.79M ﹤0.01% 8443
2022
Q1 		$2.97M Sell
61,200
-17,300
-22% -$892K ﹤0.01% 5213
2021
Q4 		$5.77M Buy
78,500
+29,300
+60% +$2.41M ﹤0.01% 4051
2021
Q3 		$4.48M Buy
+49,200
New +$4.18M ﹤0.01% 4516

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors's ASTH Position: Q1 2026 in Review

Citadel Advisors reduced its Astrana Health (ASTH) stake by 21% in Q1 2026, selling an estimated $154K and leaving 25,019 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #8791.

Citadel Advisors first reported a position in ASTH in Q3 2018 and has held it in 22 quarters since. The position peaked at $10.3M in Q3 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Citadel Advisors held 25,019 shares of Astrana Health worth $613K as of Q1 2026.
  • Citadel Advisors sold 6,485 Astrana Health shares in Q1 2026, an estimated $154K.
  • Astrana Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8791 holding.
  • Citadel Advisors first reported a position in Astrana Health in Q3 2018 and has held it in 22 quarters since.
  • Citadel Advisors's Astrana Health position peaked at $10.3M in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.